Aspirant Academy

MCQ

Dengue vaccine technology MCQ - Practice Questions with Answers

Solve 1 Dengue vaccine technology questions for RAS/RPSC preparation.

Practice questions

Q1Consider the following statements about Qdenga: 1. It is a live, attenuated, tetravalent dengue vaccine developed using recombinant DNA technology. 2. It is supplied as a ready-to-use liquid and administered intravenously. Which of the statements given above is/are correct?

A 1 only
B 2 only
C Both 1 and 2
D Neither 1 nor 2
Explanation

Statement 1 is correct: Qdenga is a live, attenuated, tetravalent vaccine developed using recombinant DNA technology. Statement 2 is incorrect: it comes as a dry powder for reconstitution and is administered by subcutaneous injection, not intravenously.

You've seen 1 of 1 sample questions

Unlimited practice on Dengue vaccine technology comes with the RAS Test Series + Practice pack or Gate Pass.

More topics in Science & Technology

Explore other subjects